Literature DB >> 24641123

Four-weekly infliximab in the treatment of severe hidradenitis suppurativa.

B Moriarty1, Z Jiyad, D Creamer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24641123     DOI： 10.1111/bjd.12713

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

Review 1.  An Update on Medical Treatment Options for Hidradenitis Suppurativa.

Authors:  I E Deckers; E P Prens
Journal:  Drugs       Date:  2016-02       Impact factor: 9.546

Review 2.  North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.

Authors:  Ali Alikhan; Christopher Sayed; Afsaneh Alavi; Raed Alhusayen; Alain Brassard; Craig Burkhart; Karen Crowell; Daniel B Eisen; Alice B Gottlieb; Iltefat Hamzavi; Paul G Hazen; Tara Jaleel; Alexa B Kimball; Joslyn Kirby; Michelle A Lowes; Robert Micheletti; Angela Miller; Haley B Naik; Dennis Orgill; Yves Poulin
Journal:  J Am Acad Dermatol       Date:  2019-03-11       Impact factor: 15.487

Review 3.  Update on hidradenitis suppurativa: connecting the tracts.

Authors:  Liza Gill; Melissa Williams; Iltefat Hamzavi
Journal:  F1000Prime Rep       Date:  2014-12-01

Review 4.  Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.

Authors:  Christina Fotiadou; Efstratios Vakirlis; Dimitrios Ioannides
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-10-19

Review 5.  Systematic review of immunomodulatory therapies for hidradenitis suppurativa.

Authors:  Shi Yu Derek Lim; Hazel H Oon
Journal:  Biologics       Date:  2019-05-13

Review 6.  TNF-α inhibitors in the treatment of hidradenitis suppurativa.

Authors:  Kevin T Savage; Kelsey S Flood; Martina L Porter; Alexa B Kimball
Journal:  Ther Adv Chronic Dis       Date:  2019-05-27       Impact factor: 5.091

Review 7.  Infliximab in hidradenitis suppurativa: A systematic review and meta-analysis.

Authors:  Terri Shih; Katrina Lee; Tristan Grogan; Devea R De; Vivian Y Shi; Jennifer L Hsiao
Journal:  Dermatol Ther       Date:  2022-07-18       Impact factor: 3.858

Review 8.  Hidradenitis suppurativa: infection, autoimmunity, or both?

Authors:  Costas A Constantinou; George E Fragoulis; Elena Nikiphorou
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-12-30       Impact factor: 5.346

Review 9.  Clinical Implementation of Biologics and Small Molecules in the Treatment of Hidradenitis Suppurativa.

Authors:  Pim Aarts; Koen Dudink; Allard R J V Vossen; Kelsey R van Straalen; Christine B Ardon; Errol P Prens; Hessel H van der Zee
Journal:  Drugs       Date:  2021-07-20       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.